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Background: Influenza A virus (IAV) infection primarily targets respiratory epithelial cells and produces clinical
outcomes ranging from mild upper respiratory infection to severe pneumonia. Recent studies have shown the
importance of lung antioxidant defense systems against injury by IAV. Nuclear factor-erythroid 2 related factor 2
(Nrf2) activates the majority of antioxidant genes.
Methods: Alveolar type II (ATII) cells and alveolar macrophages (AM) were isolated from human lungs not suitable
for transplantation and donated for medical research. In some studies ATII cells were transdifferentiated to alveolar
type I-like (ATI-like) cells. Alveolar epithelial cells were infected with A/PR/8/34 (PR8) virus. We analyzed PR8 virus
production, influenza A nucleoprotein levels, ROS generation and expression of antiviral genes.
Immunocytofluorescence was used to determine Nrf2 translocation and western blotting to detect Nrf2, HO-1 and
caspase 1 and 3 cleavage. We also analyzed ingestion of PR8 virus infected apoptotic ATII cells by AM, cytokine
levels by ELISA, glutathione levels, necrosis and apoptosis by TUNEL assay. Moreover, we determined the critical
importance of Nrf2 using adenovirus Nrf2 (AdNrf2) or Nrf2 siRNA to overexpress or knockdown Nrf2, respectively.
Results: We found that IAV induced oxidative stress, cytotoxicity and apoptosis in ATI-like and ATII cells. We also
found that AM can ingest PR8 virus-induced apoptotic ATII cells (efferocytosis) but not viable cells, whereas ATII
cells did not ingest these apoptotic cells. PR8 virus increased ROS production, Nrf2, HO-1, Mx1 and OAS1 expression
and Nrf2 translocation to the nucleus. Nrf2 knockdown with siRNA sensitized ATI-like cells and ATII cells to injury
induced by IAV and overexpression of Nrf2 with AdNrf2 protected these cells. Furthermore, Nrf2 overexpression
followed by infection with PR8 virus decreased virus replication, influenza A nucleoprotein expression, antiviral
response and oxidative stress. However, AdNrf2 did not increase IFN-λ1 (IL-29) levels.
Conclusions: Our results indicate that IAV induces alveolar epithelial injury and that Nrf2 protects these cells from
the cytopathic effects of IAV likely by increasing the expression of antioxidant genes. Identifying the pathways
involved in protecting cells from injury during influenza infection may be particularly important for developing new
therapeutic strategies.
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Influenza A virus (IAV) targets the lung epithelial cells
for infection and produces clinical outcomes ranging
from a mild upper respiratory infection to severe pneu-
monia [1,2]. Influenza viruses cause oxidative stress and
acute respiratory inflammation [3,4]. Recent studies have
focused on the role of lung antioxidant defense systems
against injury induced by this virus because they likely
play a role in virus-associated inflammation, viral sus-
ceptibility and immune clearance [5,6]. It has been
shown that antioxidant compounds inhibit influenza
virus replication and diminish the release of inflam-
matory and apoptotic mediators during virus infection
[7]. Moreover, the combination of antioxidants with
antiviral drugs synergistically reduces the lethal effects
of influenza virus infections. This suggests that agents
with antiviral and antioxidant activities could be a
strategy for the treatment of patients with severe
influenza-associated complications [8].
Epithelial cells are the primary site of viral replication
for influenza virus. Upon viral entry, IAV inhibits host
cell protein synthesis and initiates fast and efficient viral
replication. The end result of this process is host cell
apoptosis and cytotoxicity [9]. Apparently, neighboring
cells sense the presence of apoptotic cells and actively
extrude them from the monolayer [10-12].
Nuclear factor-erythroid 2 related factor 2 (Nrf2) is a
member of the family of cap’n’collar basic leucine zipper
transcription factors [6] and, although it is ubiquitously
expressed throughout the lung, it is found predomin-
antly in the epithelium and alveolar macrophages (AM)
[13]. The activation of the majority of antioxidant and
defense genes are regulated by Nrf2 through binding to
antioxidant response elements (AREs) [6]. It has been
recently reported that the antioxidant pathway con-
trolled by Nrf2 is pivotal for protection against the de-
velopment of influenza virus-induced pulmonary
inflammation and lung injury in mice in vivo under oxi-
dative conditions [6]. Nrf2 also plays a key role in host
defense against respiratory syncytial virus (RSV) in vivo
[14], and RSV infection induces down-regulation of air-
way antioxidant systems in mice [15]. Moreover, Cho
et al. reported that Nrf2 has antiviral activity in murine
models of RSV [14], and Nrf2 activation by epigallocatechin
gallate decreased viral replication in response to influenza
A/Bangkok/1/79 infection in human nasal epithelial cells
[5]. These results suggest that attenuation of oxidative
stress, inflammation and apoptosis may lessen influenza
virus-induced lung injury and exacerbation of existing re-
spiratory diseases.
Children are particularly susceptible to influenza, they
account for numerous outpatient visits, and have a cen-
tral role for spreading infection within the community
[16,17]. It has also been reported that neonatal mice aremore susceptible to A/PR/8/34 (PR8) virus than adult
mice [18]. Therefore in this study, we chose to use al-
veolar type II (ATII) cells from pediatric lung donors to
focus on the response of lung cells isolated from chil-
dren. We have recently reported the effects of influenza
on alveolar epithelial cells from adults [19].
In the current study, we used human primary alveolar
type I-like (ATI-like) and ATII cells. Alveolar type I
(ATI) cells are large flat cells that cover ~ 95% of the al-
veolar surface and through which gas exchange takes
place. ATII cells make and secrete pulmonary surfactant,
and they proliferate to restore the epithelium after dam-
age to the more sensitive ATI cells [20]. Human ATI
cells have not been isolated and cultured. We chose to
use ATI-like cells, which are type II cells cultured to trans-
differentiate into a ATI cell phenotype in vitro [20-22]. We
analyzed clearance of PR8 virus-induced apoptotic cells by
human primary AM and ATII cells. Furthermore, to im-
prove our knowledge on pathways involved in lessening the
cellular injury associated with influenza infection, we fo-
cused on the role of Nrf2 in human primary alveolar epi-
thelial cells infected with IAV. This is the first study on the
effect of IAV on ATI-like cells and to our knowledge there
is no study of the role of Nrf2 in influenza A virus infection
in cells obtained from children. Our hypothesis is that Nrf2
protects alveolar cells against injury induced by PR8 virus
by activation of antioxidant defense genes and decreasing
oxidative stress and viral replication. To test this hypothesis
we used adenovirus Nrf2 (AdNrf2) and Nrf2 siRNA strat-
egies to study the effect of Nrf2 overexpression and knock-
down, respectively in these cells infected by PR8 virus.
Methods
Donor information
Deidentified human lungs not suitable for transplant-
ation were donated for medical research from the
National Disease Research Interchange (Philadelphia,
PA) and the International Institute for the Advancement
of Medicine (Edison, NJ). For this study we selected
non-smoker lung donors (N= 6, 2-18 years old). The
Committee for the Protection of Human Subjects at Na-
tional Jewish Health approved this research. To our
knowledge this is the first report using alveolar epithelial
cells from children to study the effect of IAV.
Isolation and culture of ATII cells, ATI-like cells and AM
The ATII cell isolation method has been published pre-
viously [23,24]. Briefly, the right middle lobe was per-
fused and lavaged, and then instilled with elastase
(Roche Diagnostics, Indianapolis, IN). Subsequently, the
lung was minced and the cells were filtrated and purified
by centrifugation on a density gradient made of Optiprep
(Accurate Chemical Scientific Corp., Westbury, NY) and
by negative selection with CD14-coated magnetic beads
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coated (Sigma Chemicals Inc., St. Louis, MO) dishes. The
purity of ATII cells was ~80% before plating and over 95%
after adherence in culture [20].
The isolated ATII cells were cultured as we described
previously [19,23]. Briefly, they were resuspended in
DMEM supplemented with 10% fetal bovine serum
(FBS), 2 mM glutamine, 100 μg/ml streptomycin, 100 U/ml
penicillin (all from Thermo Scientific, Franklin, MA), 2.5
μg/ml amphotericin B (Mediatech Inc., Manassas, VA) and
10 μg/ml gentamicin (Sigma Chemicals Inc., St. Louis,
MO). To maintain their differentiated state, ATII cells were
plated for 2 d with 10% FBS on millicell inserts (Millipore
Corp., Bedford, MA) coated with a mixture of 20%
Engelbreth-Holm-Swarm tumor matrix (BD Biosciences,
San Jose, CA) and 80% rat-tail collagen (RTC) in DMEM
with additives as mentioned above and then cultured for 2
d with 1% charcoal-stripped FBS along with 10 ng/ml kera-
tinocyte growth factor (KGF, R&D Systems Inc., Minneap-
olis, MN), and for an additional 2 d with 10 ng/ml KGF,
0.1 mM isobutylmethylxanthine, 0.1 mM 8-Br-cAMP, and
10 nM dexamethasone (all from Sigma Chemicals Inc., St.
Louis, MO) [19].
To transdifferentiate ATII cells into ATI-like cells,
ATII cells were plated on RTC-coated plates or glass
coverslips in DMEM with 10% FBS for 2 d and then cul-
tured in DMEM with 5% FBS for 4 d [20] in addition to
glutamine, amphotericin B, streptomycin, penicillin, and
gentamicin as mentioned above.
AM were isolated as we previously described [25].
Briefly, the lung was lavaged with HEPES-buffered saline
and 2 mM EDTA and the lavage fluid was centrifuged at
4°C for 10 min. The resulting pellet was resuspended
and plated in DMEM supplemented with 10% FBS in
addition to glutamine, amphotericin B, streptomycin,
penicillin, and gentamicin as mentioned above. After
24 h, AM were cultured for 2 d in DMEM with 5% FBS.
Infection with PR8 virus, AdNrf2 and AdGFP
The H1N1 strain A/PR/8/34 (PR8) (used interchange-
ably with IAV throughout the manuscript) was an ori-
ginal gift from Dr. J. Abramson (Bowman Gray School
of Medicine, Winston-Salem, NC). PR8 virus was grown
in 10-day-old chicken eggs and virus-containing allan-
toic fluid was processed as previously reported [26].
ATI-like and ATII cells were infected with PR8 virus as
we described [25]. Briefly, cells were inoculated with
PBS or PR8 virus at a MOI of 0.05, 0.5 and 1 pfu/cell.
After 1 h cells were washed twice with DMEM and incu-
bated for 24 h or 48 h.
Adenovirus Nrf2 (AdNrf2) with green fluorescent pro-
tein (GFP) and adenovirus GFP (AdGFP) were obtained
from Dr. Timothy H. Murphy [27]. For adenovirus infec-
tion in ATI-like or ATII cells we used virus diluted to aMOI of 200 pfu/cell in PBS. Cells were allowed to express
transgenes for 24 h before usage. All infected cell cultures
were examined for adequate infection efficiency as
assessed by GFP fluorescence (88% for ATI-like cells and
85% for ATII cells) and by western blotting for Nrf2.
Cell transfection with Nrf2 siRNA
Nrf2 siRNA duplex showing maximum knockdown in
A549 cells (sense: 5’ CAGCAGAACUGUACCUGUUUU
3’; antisense: 3’ UUGUCGUCUUGACAUGGACAA 5’)
[28] was purchased from Dharmacon Research, Inc
(Lafayette, CO). To confirm the specificity of the inhib-
ition, the control, nontargeting (NT) siRNA was used as
negative control (sense: 5’ UAGCGACUAAACACAUCA
AUU 3’; antisense 3’ UUAUCGCUGAUUUGUGUAG
UU 5’) [28]. Cells were transfected with 100 nmol of
siRNA duplexes by using GenomONE HVJ Envelope
Vector Kit (Cosmo Bio CO. Ltd. Carlsbad, CA) accord-
ing to the manufacturer’s instructions. After 24 h, cells
were infected with PR8 virus as described above. Knock-
down of the target gene was quantified by western blot-
ting with GAPDH for normalization.
Immunocytofluorescence
To detect viral antigen, ATI-like cells were fixed with
methanol and blocked with 3% normal donkey serum
(Jackson ImmunoResearch; West Grove, PA) in PBS. The
cells were incubated with an antibody specific to influenza
A nucleoprotein (Millipore Corp., Billerica, MA) and anti-
cytokeratin MFN116 (Dako, Carpinteria, CA). The sec-
ondary antibody, Alexa Fluor 594 IgG (Invitrogen Corp.,
Carlsbad, CA) and Alexa Fluor 488 IgG were applied for
1 h. Cells were mounted with Vectashield medium con-
taining DAPI (Vector Laboratories, Burlingame, CA).
The same protocol was used to detect Nrf2 transloca-
tion in ATI-like cells, ATII cells and AM infected with
PR8 virus. Cells were incubated with rabbit anti-Nrf2 anti-
body (Santa Cruz Biotechnology Inc., Santa Cruz, CA)
and subsequently with Alexa Fluor 594 anti-rabbit IgG.
To detect oxidative stress induced by PR8 virus we ap-
plied rabbit anti-4-hydroxynonenal (4-HNE) antibody
(Abcam, Cambridge, MA). 4-HNE is a product of lipid
peroxidation and hence a marker of oxidative stress. We
used Alexa Fluor 594 anti-rabbit IgG as described above.
Efferocytosis
Floating ATII cells were collected from control cells and
cells infected at a MOI of 1 pfu/cell PR8 virus for 48 h.
The latter ones contained around 70% apoptotic cells as
detected by ethidium bromide and acridine orange
double staining (data not shown). This method is more
sensitive than TUNEL (TdT-mediated dUTP Nick-End
Labeling) assay and allows distinguishing early and late
apoptotic cells from necrotic or alive cells [23]. To study
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Linker Kit and PKH2 Green Fluorescent Phagocytic Cell
Linker Kit (both from Sigma, St. Louis, MO) according
to the manufacturer’s instructions. PKH2 labeled AM
were incubated with PKH26 labeled floating ATII cells
(ratio 1:10) for 3 h. Cells were mounted with Vectashield
medium containing DAPI. A minimum 200 AM were
counted. The phagocytic index was calculated using the
following formula: ((number of apoptotic bodies)/(200
total macrophages)) x 100 [29].
Detection of necrotic cells using propidium iodide and
Hoechst 33342 double staining
To distinguish between live and necrotic cells 10 mg/ml
Hoechst 33342 and 1 mg/ml propidium iodide (both
from Sigma Chemicals Inc., St. Louis, MO) were used
for a double staining. Three hundred cells were analyzed
in each of three independent experiments [30].
Western blotting
Expression of proteins was measured by western blotting
according to the protocol described previously [23]. Pro-
tein loading was normalized to GAPDH. We used
mouse anti-GAPDH, rabbit anti-caspase 3 and rabbit
anti-caspase 1 (all from Abcam, Cambridge, MA), mouse
anti-HO-1 (Assay Designs, Ann Arbor, MI), rabbit anti-
Nrf2 (Santa Cruz Biotechnology, Santa Cruz, CA) and
mouse anti-influenza A nucleoprotein (Millipore, Corp.,
Bedford, MA). The blots were then developed using an
enhanced chemiluminesence (ECL) western blotting kit
according to the manufacturer’s instructions (Amersham
Pharmacia Biotech, Piscataway, NJ). Images obtained
were quantitated using NIH Image 1.62 software.
Real-time PCR
Total RNA was isolated from cells using the RNeasy
Mini kit (Qiagen, Valencia, CA) according to the manu-
facturer’s recommendations. Taqman qPCR was per-
formed on a CFX C1000 CFX96 Thermocycler (Biorad,
Hercules, CA). Probes and cycling condition were opti-
mized in accordance with MIQE guidelines for PCR [31].
Gene expression levels were calculated as a ratio to the ex-
pression of the reference gene, GAPDH and data were ana-
lyzed using the ΔΔCt method. The probes for Nrf2, HO-1,
Mx1 and OAS1 were designed by the manufacturer and
purchased from Applied Biosystems (Carlsbad, CA).
Plaque assay
Plaque assay was performed as we previously described
[32]. Briefly, medium from PR8 virus infected ATI-like
cells was serially diluted in DMEM and used to inoculate
Madin-Darby canine kidney (MDCK) cells. Confluent
MDCK cells were infected with PR8-infected ATI-like
cell supernatant for 1 h at 37°C. The inoculum wasremoved and the cells were overlaid with MEM, FBS, anti-
biotics and SeaKem LE Agarose (Cambrex, Rockland, ME).
Plaques were stained after 72 h incubation at 37°C, with the
agarose overlay medium containing 6% Neutral Red (Sigma,
St. Louis, MO).ELISA
IL-8 and IL-29 (IFN-λ1) were measured by ELISA
(ELISA Tech., Aurora, CO) in the ATI-like and ATII cell
culture supernatant according to the manufacturer's
recommendations. We used a MicroQuant microplate
spectrophotometer (BioTek Instruments, Winooski, VT)
and analyzed with KCjunior Data Analysis Software.ROS production
We compared ROS production in ATI-like and ATII
cells transfected with Nrf2 siRNA or AdNrf2 followed
by infection with PR8 virus at a MOI of 0.5 pfu/cell for
24 h. We used the Amplex Red Hydrogen Peroxide
Assay Kit (Invitrogen Corp., Carlsbad, CA) as a quantiti-
tative index of ROS generation [33]. Because H2O2 is
one of the most stable forms of ROS, this detection
method allows observation of oxidation processes in real
time. Amplex Red reacts with hydrogen peroxide in the
presence of horseradish peroxidase (HRP) with a 1:1
stoichiometry to form resorufin. Briefly, 50 μl of samples
and standards were mixed with 50 μl of 100 μM Amplex
Red and 0.2 U/ml HRP solution and incubated for 30
min at room temperature. Absorbance was measured at
560 nm and calculated concentrations were normalized
to protein content.Glutathione measurement
ATI-like cells and ATII cells were cultured and infected
at a MOI of 0.5 pfu/cell PR8 virus for 24 h. Total gluta-
thione (GSH) was analyzed as previously described
[34,35]. Briefly, GSH was measured by mixing 100 μl of
1:1 3 U/ml glutathione reductase with 0.67 mg/ml 5,5’-
Dithiobis (2-nitrobenzoic acid, DTNB) with sample or
standard. The reaction was initiated by the addition of
50 μl of 0.67 mg/ml NADPH (all from Sigma, St. Louis,
MA) Absorbance was measured spectrophotometrically
at 412 nm and obtained values were normalized to pro-
tein content.Statistical analysis
One-way ANOVA by GraphPad Prism 4 was used to
evaluate statistical differences among experimental groups.
A Dunnett’s test was applied and a value of p < 0.05 was
considered significant. Data are shown here as the mean ±
SEM from three independent experiments.
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PR8 virus infects ATI-like cells
We wanted to study the role of Nrf2 and oxidative injury
during influenza infection. In this report we focused
mostly on ATI-like cells. The alveolar wall is covered
primarily by ATI cells and these cells are more sensitive
to oxidative injury than ATII cells. Our initial study was
simply to document that ATI-like cells could be infected
at comparable levels to our previous observations with
ATII cells [19]. We used cytokeratin MFN 116 as a mar-
ker of ATI-like cells, and we found that PR8 virus readily
infected these cells (Figure 1) similar to what we have
observed with ATII cells.
PR8 virus induces apoptosis and cytoxicity in alveolar
epithelial cells
IAV induces apoptosis and secondary necrosis in vitro
because of the lack of phagocytes. We wanted to study
the role of Nrf2 in preventing cell injury, therefore, we
determined the extent of cytotoxicity of PR8 virus,
which can result in apoptosis and/or necrosis. We
observed necrosis in cells infected with PR8 virus and a
higher percentage of necrotic ATI-like cells than ATII
cells (Additional file 1: Figure S1). We used TUNEL
assay to determine whether MOI of 0.05, 0.5 or 1 pfu/
cell PR8 virus induces apoptosis after 24 h or 48 h. We
observed morphological characteristics of apoptosis
(Additional file 2: Figure S2, Panel I) and a higher per-
centage of apoptotic cells in the floating cell population
than attached ATI-like and ATII cells (Additional file 2:
Figure S2, Panel II). We also found a statistically signifi-
cant higher percentage of apoptotic ATI-like cells than
ATII cells, which suggests that these cells are more sen-
sitive to injury induced by PR8 virus.
Subsequently, we wanted to document that apoptosis
induced by PR8 virus in alveolar cells is associated with
caspase activation. We observed caspase 1 and caspase 3
cleavage (Figure 2) and also PARP cleavage (data not
shown) in a concentration-dependent manner after ATI-
like and ATII cell infection with PR8 virus at 24 hpi andFigure 1 PR8 virus infects ATI-like cells. ATI-like cells were cultured in D
for 4 d. These cells were inoculated with PR8 virus for 1 h at a MOI of 1 pfu
immunocytofluorescent stain using IAV antibody (red), cytokeratin MFN116
like cells inoculated with PR8 virus. Representative pictures are from three i48 hpi. Hence, these results indicate that PR8 virus
induces apoptosis and necrosis.
Alveolar macrophages, but not epithelial cells ingest
apoptotic viral infected ATII cells
One of the major questions related to apoptosis is what
happens to the viral-induced apoptotic cells. Virus-
infected cells undergo apoptosis and ingestion of apoptotic
cells leads to inhibition of virus spread in vivo [36]. When
epithelial cells undergo apoptosis, the non-apoptotic epi-
thelial cells actively extrude the apoptotic cells from the
monolayer in an actin-dependent process [11,12].
We wanted to determine potential clearance routes for
the apoptotic cells [10]. We analyzed uptake of viral
infected apoptotic or viable ATII cells by AM or ATII
cells. We found significant ingestion of apoptotic ATII
cells by AM (Figure 3). In addition, under these same
conditions ATII cells did not ingest apoptotic ATII cells
(data not shown). Removal of apoptotic cells by AM
avoids secondary necrosis and the release of cell con-
tents that may promote further inflammation [37]. Our
observation that AM ingest influenza A virus-induced
apoptotic cells may further improve strategies aimed on
the increasing efferocytosis by these cells that may pre-
vent excessive inflammation and pneumonia.
PR8 virus induces Nrf2 and HO-1 expression and
translocation to the nucleus
We found that PR8 virus at a MOI of 0.5 pfu/cell signifi-
cantly increased Nrf2 and downstream HO-1 mRNA
levels in ATI-like cells, ATII cells and AM after 48 h
(Figure 4, Panel I). We also verified these results on the
protein level and observed by immunoblotting higher
Nrf2 and HO-1 expression in these cells after treatment
with IAV (Figure 4, Panel II).
We also found Nrf2 translocation to the nucleus in
ATI-like cells, ATII cells and AM infected at a MOI of
0.5 pfu/cell PR8 virus for 48 h in comparison with con-
trols (Figure 5). Our results indicate induction of the
Nrf2 pathway in these cells in response to IAV infection.MEM with 10% FBS for 2 d and then cultured in DMEM with 5% FBS
/cell and harvested at 48 hpi. Representative picture of positive
(green) and DAPI (blue): Panel a – mock infected cells; Panel b – ATI-
ndependent experiments.
Figure 2 Caspase 1 and caspase 3 cleavage induced by PR8 virus in ATI-like and ATII cells. Cells were cultured as described in the Method
section and infected at a MOI of 0.05, 0.5 and 1 pfu/cell PR8 virus for 24 h or 48 h. Cleaved caspase 1 and 3 were detected in ATI-like cells (Panel
I) and in ATII cells (Panel II) by immunoblotting. Lane 1 – control, Lane 2 – MOI of 0.05 pfu/cell, Lane 3 – MOI of 0.5 pfu/cell, Lane 4 – MOI of 1
pfu/cell. Representative pictures from three independent experiments.
Figure 3 AM ingest PR8 virus-induced apoptotic ATII cells. ATII cells were infected with IAV and floating apoptotic cells were collected after
48 h. Floating cells (red) were separately fluorescently stained and added to labeled AM (green) as described in the Methods section. a – AM
alone; b – apoptotic floating ATII cells induced by a MOI of 1 pfu/cell PR8 virus after 48 h; c – ingestion of PR8 virus-induced apoptotic ATII cells
by AM; d – percent of efferocytosis of viable ATII cells and PR8 virus-induced apoptotic ATII cells by AM. Data represent results from three
independent experiments (Mean ± SEM, * p< 0.05).
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Figure 4 PR8 virus induces Nrf2 and HO-1 expression. ATI-like cells (a), ATII cells (b) and AM (c) were grown as described in the Methods
section, infected at a MOI of 0.5 pfu/cell PR8 virus for 48 h. Panel I, relative expression of Nrf2 and HO-1 as detected by RT-PCR. Panel II, Nrf2 and
HO-1 expression in alveolar cells (immunoblotting). Lane 1 – control; lane 2 – MOI of 0.5 pfu/cell PR8 virus. Relative expression of these proteins is
also shown. Data represent results from three independent experiments (Mean ± SEM, * p< 0.05).
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induced by PR8 virus
Nrf2 translocation to the nucleus indicates activation of
the antioxidant defense system mediated by Nrf2. To
further study the role of the Nrf2 pathway, we overex-
pressed Nrf2 in ATI-like cells (Figure 6, Panel I). We
infected ATI-like cells with AdNrf2 followed by PR8
virus (Figure 6, Panel II). We found a significantly higher
percentage of necrotic cells after cell infection with PR8
virus alone. The highest percentage of necrotic cells
(14.1%) was observed at a MOI of 1 pfu/cell. Further-
more, we observed a significant decrease in the percent-
age of necrotic cells after ATI-like cell infection with
AdNrf2 followed by a MOI of 0.5 or 1 pfu/cell PR8 virus
in comparison with PR8 virus alone.
To determine the potential mechanisms mediating the
decreased cell injury after PR8 infection due to Nrf2
overexpression, we assessed oxidative stress. To do this
we analyzed the level of 4-HNE. PR8 virus induced oxi-
dative stress and 4-HNE immunostaining was decreasedafter cell infection with AdNrf2 followed by PR8 virus
(Figure 7, Panel I). To further investigate the mechan-
isms responsible for ATI-like cell protection after Nrf2
overexpression, we evaluated the expression of HO-1,
which is a well-defined target of Nrf2 and induced by
oxidative stress (Figure 7, Panel II). We found that PR8
virus significantly increases HO-1 level, and this expres-
sion was decreased after infection with AdNrf2 followed
by PR8 virus. These results suggest that infection of
ATI-like cells with PR8 virus induces oxidative stress,
which was diminished by Nrf2 overexpression.
Next we wanted to determine whether AdNrf2 affects
IAV replication. Culture media from ATI-like cells
inoculated with PR8 virus were collected and titrated by
plaque assay. We found that infection with AdNrf2 fol-
lowed by IAV slightly decreased PR8 virus titer released
into the media (Figure 7, Panel III). We also observed a
significant increase in influenza A nucleoprotein expres-
sion in ATI-like cells infected with PR8 virus at a MOI
of 1 pfu/cell and a slight decrease after infection with
Figure 5 Nrf2 translocation to the nucleus. ATI-like cells (Panel I), ATII cells (Panel II) and AM (Panel III) were infected at a MOI of 0.5 pfu/cell
PR8 virus and Nrf2 activation was observed by its translocation to the nucleus. a – Cytoplasmic localization of Nrf2 in control cells; b - Nuclear
translocation of Nrf2 after infection with PR8 virus (immunocytofluorescence). Representative pictures from three independent experiments.
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results suggest that Nrf2 overexpression decreased viral
replication in ATI-like cells.
To determine the potential mechanisms mediating
decreased IAV replication after infection with AdNrf2,
we assessed antiviral immune response mediators. Spe-
cifically, we analyzed the effect of AdNrf2 alone or Nrf2
overexpression followed by infection with PR8 virus on
the interferon-induced Mx1 and the OAS1 genes, which
are involved in the innate immune response to viral in-
fection [25]. Nrf2 overexpression did not increase Mx1
and OAS1 mRNA (Figure 7, Panel IV). However, infec-
tion with AdNrf2 followed by PR8 virus significantly
reduced expression of these genes in comparison withIAV alone which indicates cytoprotective mechanisms
orchestrated by Nrf2 against cell injury by IAV.
In summary, our data demonstrate that expression level
of Nrf2 plays a role in decreasing infection of IAV in ATI-
like cells by antiviral activity of Nrf2, reducing oxidative
stress and induction of cellular defense systems.
Nrf2 overexpression increases IL-8 but not IL-29 secretion
To further investigate the mechanism of Nrf2 protection
against IAV we analyzed cytokine levels. PR8 virus sig-
nificantly increased IL-8 secretion in comparison with
untreated controls (Figure 8, Panel I). Unexpectedly, we
observed a much higher IL-8 secretion by AdNrf2 in
comparison with cells infected with AdGFP in ATI-like
Figure 6 AdNrf2 protects ATI-like cells against injury by PR8 virus. ATI-like cells were infected for 24 h at a MOI of 200 pfu/cell AdNrf2 or
AdGFP as described in the Methods section. Panel I – Nrf2 was overexpressed by AdNrf2 and cells were harvested at 24 hpi: Lane 1 - control;
lane 2 - AdNrf2, lane 3 - AdGFP (immunoblotting). Relative expression of this protein is also shown. Panel II – Cells were infected with AdNrf2
followed by infection at a MOI of 0.05, 0.5 and 1 pfu/cell IAV for 24 h. A higher percentage of necrotic cells was observed in cells infected with
PR8 virus in comparison with cells infected with AdNrf2 and followed by infection with PR8 as detected by Hoechst 33342 and propidium iodide
double staining. * Statistically significant increase in the percentage of necrotic cells by PR8 infection in comparison with control. # Statistically
significant decrease of ATI-like necrotic cells after infection with AdNrf2 and PR8 in comparison to PR8 virus alone (Mean ± SEM, N= 3, p< 0.05).
Data represent results from three independent experiments.
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We also found that PR8 virus significantly increased IL-29
secretion in ATI-like cells (Figure 8, Panel II, a) and ATII
cells (Figure 8, Panel II, b). IAV induced higher IL-29 ex-
pression in ATI-like than ATII cells. However, we did not
observe higher IL-29 levels after cell infection with AdNrf2
or AdGFP. These results confirm our previous observations
that the interferon response to PR8 virus is not altered by
Nrf2 levels.
Nrf2 knockdown sensitizes cells to injury induced by PR8
virus
To verify our results of the protective role of the Nrf2
pathway in cells infected with PR8 virus, we knocked
down Nrf2 and then infected cells with PR8 virus. We
were able to knockdown Nrf2 in ATI-like cells using Nrf2
siRNA (Figure 9, Panel I). We found that Nrf2 knockdown
followed by infection with PR8 virus increased the cyto-
toxicity for all applied virus concentrations in comparisonwith PR8 virus alone (Figure 9, Panel II). This indicates
that Nrf2 knockdown sensitizes ATI-like cells to injury
induced by PR8 virus and Nrf2 level modulates cell injury
by IAV.
PR8 virus generates ROS
Among the methods commonly used to measure H2O2,
AmplexRed has several advantages. The ability to simply
and accurately calibrate signals to peroxide concentra-
tions offers the opportunity to carefully quantitate the
production of oxidants by biological systems [33]. We
transfected ATI-like cells and ATII cells with Nrf2
siRNA or AdNrf2 followed by infection at a MOI of 0.5
pfu/cell PR8 virus for 24 h. We found significantly
higher ROS generation in cells transfected with Nrf2
siRNA followed by infection with PR8 virus in compari-
son with IAV alone (Figure 10, Panel I). To complete
our results we also infected these cells with AdNrf2 fol-
lowed by PR8 virus and we found lower ROS generation
Figure 7 AdNrf2 decreases IAV infection in ATI-like cells. Cells were infected at a MOI of 200 pfu/cell AdNrf2 followed by infection at a MOI
of 1 pfu/cell PR8 virus for 24 h. Panel I – Oxidative stress was measured by immunocytofluorescence with an antibody to 4-HNE as described in
the Methods section. a - control; b – AdGFP, c - AdNrf2; d – PR8 virus; e - AdNrf2 and PR8 virus. Panel II – Infection with PR8 virus significantly
increased influenza A nucleoprotein and HO-1 expression. Infection with AdNrf2 followed by PR8 virus decreased their expression
(immunoblotting). Lane 1- control; lane 2 – AdGFP; lane 3 - AdNrf2; lane 4 – PR8 virus; and lane 5 - AdNrf2 and PR8 virus. Relative expression of
these proteins is also shown. Panel III – AdNrf2 decreased replication of PR8 virus in comparison with PR8 alone. Cells were infected with IAV or
AdNrf2 followed by infection with PR8 virus. Media were harvested 24 h after inoculation and titrated by plaque assay in MDCK cells as described
in the Methods section. Panel IV – IAV increases antiviral gene Mx1 and OAS1 mRNA levels as measured by RT-PCR. Infection with AdNrf2
followed by PR8 virus significantly decreased their expression. * Statistically significant increase in the gene expression in comparison with
control. # Statistically significant decrease in comparison with PR8 virus alone (Mean ± SEM, N= 3, p< 0.05).
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protective role of Nrf2 against ROS generation by PR8
virus and are in agreement with a positive staining using
4-HNE (Figure 7).
AdNrf2 increases glutathione level
To determine the protective mechanism of Nrf2 against
oxidative stress induced by IAV we measured GSH level
in ATI-like and ATII cells transfected with Nrf2 siRNA
or AdNrf2 followed by infection at a MOI of 0.5 pfu/cell
PR8 virus for 24 h. We found significantly lower levels
of GSH after cell tranfection with Nrf2 siRNA followed
by infection with PR8 virus (Figure 10, Panel II). More-
over, AdNrf2 increased GSH levels, which protected
cells against injury by IAV. These results indicate thatthe protective role of Nrf2 against cell injury induced by
PR8 virus is in part by increasing glutathione levels.
Discussion
To date, whether or to what extent oxidative stress con-
tributes to the highly virulent property of influenza virus
is not fully known. We observed that PR8 virus induced
oxidative stress, cell injury, apoptosis, and proinflamma-
tory cytokine secretion in ATI-like cells and ATII cells.
In order to protect cells from injury induced by the PR8
virus, host cells must activate some defense against oxi-
dative stress. Nrf2 is critical factor and can activate anti-
oxidant response genes. Ours is a novel approach in that
first, we studied the response of ATI-like cells infected
with IAV, second, compared the effect of PR8 virus on
Figure 8 AdNrf2 increases IL-8 secretion but does not alter the IL-29 response. IL-8 (Panel I) and IL-29 (Panel II) were analyzed in ATI-like
(a) and ATII (b) cells by ELISA. ATI-like or ATII cells were cultured as described in the Methods section. Cells were infected at a MOI of 1 pfu/cell
PR8 virus, infected with AdNrf2 or AdGFP for 24 h and/or followed by infection with PR8 for 24 h or 48 h. * Statistically significant increase in
cytokine secretion in comparison with control (Mean ± SEM, p< 0.05). Data represent results from three independent experiments.
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same donors and third, to our knowledge this is the first
report on the role of Nrf2 in alveolar cells infected with
influenza A virus.
Our results clearly show that Nrf2 regulates alveolar
cells’ susceptibility to infection and injury induced by
PR8 virus. We confirmed our hypotheses and demon-
strated the protective role of Nrf2 against PR8 virus in-
fection. To our knowledge there are only two reports on
the role of Nrf2 and influenza virus. These studies were
performed in human nasal epithelial cells in vitro [5]
and in mice in vivo [6]. Cigarette smoke-exposed Nrf2-/-
mice showed higher rates of mortality than did wild-type
mice after IAV infection, with higher peribronchial in-
flammation, lung permeability damage, and mucus
hypersecretion. It has been recently reported that supple-
mentation with the potent Nrf2 activator epigallocatechin
gallate significantly decreased influenza A/Bangkok/1/79
virus entry and replication in nasal epithelial cells [5]. The
suppressive effect of this compound on viral replication
was abolished in cells with knocked down Nrf2 expression.
This suggests a relationship between induction of the Nrf2
pathway and the ability to protect against viral infection.
Our results are in agreement with these findings. We found
Nrf2 translocated to the nucleus in ATI-like cells, ATII cells
and AM infected with PR8 virus. We also showed signifi-
cant induction of Nrf2 and downstream HO-1. This sug-
gests activation of the Nrf2 pathway in response to IAVinfection. We also observed the protective effect of Nrf2
against IAV in human alveolar cells. We found that Nrf2
overexpression using AdNrf2 decreased IAV replication, in-
fluenza A nucleoprotein expression, antiviral gene expres-
sion, ROS generation and oxidative stress in comparison
with PR8 virus alone. Furthermore, AdNrf2 also increased
GSH level in ATI-like and ATII cells, which protected
against injury by PR8 virus. Shih et al. [27] also observed
higher intracellular GSH levels in neurons infected with
AdNrf2, which protected against oxidative stress and GSH
has been reported to be an inhibitor of IAV infection [38].
Moreover, we found that Nrf2 knockdown followed by in-
fection with PR8 virus decreased cell viability, increased
ROS generation and decreased GSH levels. Kesic et al. [5]
observed that epigallocatechin gallate increased expression
of antiviral genes RIG-1, IFN-β and Mx1. However, these
authors suggested that their expression can be Nrf2-
independent or that the effects are species and/or cell-type
specific. We found that AdNrf2 did not induce mRNA
levels of the antiviral genes Mx1 and OAS1. Our results
can be explained by a different strategy to overexpress Nrf2
and/or the cell type studied. Moreover, to our knowledge,
essential Nrf2 binding sites have not been identified in pro-
moters of any of these genes [5]. Our results are also in
agreement with studies of gene expression profiling Nrf2 in
mice showing that there are no differences in the antiviral
or interferon responsive genes [5,39,40]. Our results suggest
that the activation of antioxidant and cytoprotective
Figure 9 Nrf2 knockdown sensitizes ATI-like cells to PR8 virus. ATI-like cells were transfected with 100 nmol Nrf2 siRNA or NT siRNA for 24 h
as described in the Methods section. Panel I – Nrf2 was knocked down by Nrf2 siRNA in cells harvested at 24 hpi: Lane 1 – control; lane 2 - NT
siRNA; lane 3 - Nrf2 siRNA (immunoblotting). Relative expression of these proteins is also shown. Panel II – A higher percentage of necrotic cells
was observed in cells transfected with Nrf2 siRNA for 24 h and followed by infection with PR8 virus for 24 h in comparison with cells infected
with PR8 virus alone. * Statistically significant increase in percentage of necrotic cells induced by PR8 virus in comparison with control.
# Statistically significant increase of ATI-like necrotic cells after transfection with Nrf2 siRNA followed by PR8 in comparison with PR8 virus alone.
Data represent results from three independent experiments (Mean ± SEM, * p< 0.05).
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are responsible for cell protection against IAV. To our
knowledge, this is the first observation on the antiviral role
of Nrf2 in human alveolar epithelial cells.
We found that MOI of 1 pfu/cell PR8 virus induces
IL-8 and IL-29 secretion in ATI-like and ATII cells. Sur-
prisingly, we observed that AdNrf2 increased IL-8 levels
but not IL-29. It was postulated that the Nrf2/antioxi-
dant response pathway regulates IL-8 expression and
Nrf2-dependent RNA binding protein may directly stabilize
IL-8 mRNA [41,42]. The protective effect of Nrf2 also sug-
gests that under certain circumstances, IL-8 might have a
protective function and serves an anti-inflammatory role in
remodeling during the resolution of inflammation.
Apoptosis induced by influenza virus has been shown
in a variety of cell lines [43-45]. We observed both ne-
crosis and apoptosis induced by PR8 virus in primary
human ATI-like and ATII cells. We found chromatin
fragmentation and condensation in attached cells andfloating apoptotic cells after infection with PR8 as
detected by TUNEL assay. Floating murine primary
apoptotic macrophages were observed after treatment
with PR8 virus [46]. Furthermore, Eckardt-Michel et al.
[47] found that the fusion protein of RSV also induced
floating cells that have characteristics of the apoptotic
DNA ladder, which suggests that they are extruded from
the monolayer before late apoptotic events became ap-
parent. In our studies these floating viral infected apop-
totic cells were ingested by AM but not by ATII cells.
These results suggest that inflammatory macrophages
not the resident epithelial cells are likely responsible for
clearing IAV-induced apoptotic cells. This is different
from the involutional mammary gland where the epithe-
lium itself is responsible for clearing the apoptotic epi-
thelial cells [10,11].
To investigate the characteristics of the onset of apop-
tosis ATI-like and ATII cells infected with PR8 virus, we
measured caspase 1 and 3 cleavage. Our results are in
Figure 10 AdNrf2 protects cells and Nrf2 siRNA sensitizes cells to injury induced by PR8 virus. ATI-like cells (a) and ATII cells (b) were
grown as described in the Methods section and infected with PR8 virus at a MOI of 0.5 pfu/cell for 24 h. Panel I, cell infection with AdNrf2
followed by infection with PR8 virus decreased ROS generation in comparison with PR8 alone as measured by Amplex Red kit. Cell transfection
with Nrf2 siRNA followed by infection with PR8 virus increased ROS production in comparison with PR8 alone. * Statistically significant difference
in comparison with control. # Statistically significant decrease in comparison with PR8 virus alone. & - Statistically significant increase in
comparison with PR8 virus alone. Data represent results from three independent experiments. Panel II, AdNrf2 increased GSH level in comparison
with control. Cell transfection with Nrf2 siRNA followed by infection with PR8 virus decreased GSH level in comparison with PR8 virus alone.
* Statistically significant difference in comparison with control. # Statistically significant increase in comparison with PR8 virus alone. & - Statistically
significant decrease in comparison with PR8 virus alone. Data represent results from three independent experiments (Mean ± SEM, * p< 0.05).
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and PARP cleavage in ATII cells isolated from adult lung
donors and infected at a MOI of 0.5 pfu/cell PR8 for 24 h
[19]. This is the first study on the effect of IAV on ATI-like
cells and the results are in agreement with studies showing
involvement of caspases in apoptosis upon influenza virus
infection in cell lines and human monocyte-derived macro-
phages [43,48,49].
In summary, the effects of Nrf2 activation during in-
fluenza infections are complex. There is inhibition of
viral replication, which might be due to reduced viral
entry [5]. There is apparently no alteration in the anti-
viral genes examined or in the interferon response.
There is a significant antioxidant pro-survival response
typical for the Nrf2 pathway in oxidative stress.Conclusions
We used ATI-like, ATII cells and AM to study a re-
sponse to IAV and to show for the first time, the protect-
ive role of Nrf2 in human alveolar cells. Our results
suggest that Nrf2 is involved in the cellular antioxidant
defense system, is activated upon infection with PR8virus, and protects the host from the cytopathic effects
of oxidative stress induced by IAV in interferon-
independent manner. Taken together, our results indi-
cate that Nrf2 is an important factor that can modify the
response to PR8 virus. Identifying the pathways involved
in the cell response to this infection are particularly im-
portant for new therapeutic strategies. Nevertheless, this
study will need to be compared with cells from other
vulnerable populations, such as cigarette smokers, and
patients with chronic obstructive pulmonary disease.
Additional studies will be necessary to fully understand
the role of Nrf2 in the pathogenesis of viral pneumonia
(Additional file 3).
Additional files
Additional file 1: Figure S1. ATI-like cells are more sensitive to PR8
virus. ATI-like (Panel I) and ATII (Panel II) cells were infected with PR8 virus
at a MOI of 0.05, 0.5 or 1 pfu/cell and cell viability was assessed 24 h and
48 h after cell inoculation. The percent of cells that were injured as
measured by Hoechst 33342 and propidium iodide double staining is
shown. There was much more injury in the floating cells (b) than the
attached cells (a). * - Statistically significant increase in percentage of
necrotic cells induced by PR8 virus in comparison with control.
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http://respiratory-research.com/content/13/1/43# - Statistically significant increase of ATI-like necrotic cells in comparison
with necrotic ATII cells after infection with A/PR/8/3 virus. Data represent
results from three independent experiments (p<0.05).
Additional file 2: Figure S2. PR8 virus induces apoptosis in ATI-like cells
and ATII cells. Representative pictures of apoptotic cells infected with IAV
and detected by TUNEL assay. Panel I – Morphological characteristics of
apoptosis in ATI-like cells infected at a MOI of 1 pfu/cell PR8 virus and
harvested at 48 hpi: A - chromatin condensation in attached apoptotic
cells; B – chromatin fragmentation in attached apoptotic cells; C –
floating apoptotic cells (cytospin). Green are TUNEL-positive cells. Panel II
– Quantation of apoptosis in attached and floating ATI-like (a) and ATII
(b) cells infected at a MOI of 0.05, 0.5 and 1 pfu/cell PR8 virus as
described in Method section. * Statistically significant increase in
percentage of apoptotic cells induced by PR8 virus in comparison with
control. # Statistically significant increase of attached or floating ATI-like
apoptotic cells in comparison with attached or floating apoptotic ATII
cells, respectively after infection with PR8 virus. Data represent results
from three independent experiments (p<0.05).
Additional file 3: This manuscript contains an online supplement
with additional method.
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